PCBP2 and hepatocellular carcinoma: Kaplan-Meier survival analysis demonstrated that patients with HCC who had low levels of PCBP2 exhibited increased disease-free survival and overall survival compared to those with high levels of PCBP2 (Figure S4B, C).